Zealand Pharma A/S (ZEAL.CO)

DKK 446.1

(-1.26%)

Total Assets Summary of Zealand Pharma A/S

  • Zealand Pharma A/S's latest annual total assets in 2023 was 3.19 Billion DKK , up 107.75% from previous year.
  • Zealand Pharma A/S's latest quarterly total assets in 2024 Q2 was 10.15 Billion DKK , up 183.14% from previous quarter.
  • Zealand Pharma A/S reported annual total assets of 1.53 Billion DKK in 2022, down -25.53% from previous year.
  • Zealand Pharma A/S reported annual total assets of 2.06 Billion DKK in 2021, up 7.43% from previous year.
  • Zealand Pharma A/S reported quarterly total assets of 3.58 Billion DKK for 2024 Q1, up 12.13% from previous quarter.
  • Zealand Pharma A/S reported quarterly total assets of 3.19 Billion DKK for 2023 FY, up 107.75% from previous quarter.

Annual Total Assets Chart of Zealand Pharma A/S (2023 - 2007)

Historical Annual Total Assets of Zealand Pharma A/S (2023 - 2007)

Year Total Assets Total Assets Growth
2023 3.19 Billion DKK 107.75%
2022 1.53 Billion DKK -25.53%
2021 2.06 Billion DKK 7.43%
2020 1.92 Billion DKK 20.32%
2019 1.59 Billion DKK 30.06%
2018 1.22 Billion DKK 66.81%
2017 737.23 Million DKK 6.13%
2016 694.62 Million DKK 9.44%
2015 634.68 Million DKK 6.36%
2014 596.75 Million DKK 72.02%
2013 346.91 Million DKK -33.41%
2012 520.98 Million DKK 10.97%
2011 469.48 Million DKK 4.2%
2010 450.55 Million DKK 183.94%
2009 158.67 Million DKK -29.55%
2008 225.24 Million DKK -14.48%
2007 263.36 Million DKK 0.0%

Peer Total Assets Comparison of Zealand Pharma A/S

Name Total Assets Total Assets Difference
ALK-Abelló A/S 6.72 Billion DKK 52.44%
Bavarian Nordic A/S 14.35 Billion DKK 77.713%
Genmab A/S 35.28 Billion DKK 90.935%
Gubra A/S 625.28 Million DKK -411.59%
Novo Nordisk A/S 314.48 Billion DKK 98.983%
Orphazyme A/S 19.31 Million DKK -16464.173%
Pharma Equity Group A/S 81.33 Million DKK -3832.96%